The state of Texas currently has 25 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Recruiting
The purpose of this study is to assess the pharmacokinetics (PK), efficacy, and safety of nemolizumab in pediatric participants with moderate-to-severe atopic dermatitis (AD).
Gender:
ALL
Ages:
Between 2 years and 12 years
Trial Updated:
04/05/2023
Locations: Galderma Investigational Site #9931, Beaumont, Texas +1 locations
Conditions: Moderate-to-Severe Atopic Dermatitis